Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality
HIF-dependent antitumorigenic effect of antioxidants in vivo
GHK-Cu is a naturally occurring tripeptide that binds copper ions and has proposed roles in tissue repair, anti-inflammation, and follicle regeneration
Manage side effects proactively Common side effects of semaglutide, especially nausea, can sometimes interfere with healthy eating
226.Ezeamii VC, Okobi OE, Wambai-Sani H, et al
Targeting the biology of aging